News7 months ago
Altimmune mourns the passing of CFO Richard Eisenstadt
Altimune, Inc. GAITHERSBURG, Md., June 26, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Richard Eisenstadt, the company’s chief...
